An interventional study of Virtual Reality and Field Training (VRFT) in Stroke, sponsored by McGill University. Recruiting at 2 sites in Canada. Open to participants aged 40 Years to 74 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by McGill University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Stroke by McGill University — 7 open to participants now, 7 under way, none of them phase 3. Stroke · McGill University.
Among the 16 studies in Stroke by McGill University, this one is the 8th largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2021, is one of 15 with no phase, and was the 8th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 16 studies in Stroke by McGill University are open now, in 1 country. Recruiting first, the newest first:
McGill University · Sites in Canada
Ages 40–80
McGill University · Sites in Canada
Ages 40–84
McGill University · Sites in Canada
Ages 40–74
McGill University · Sites in Canada
Ages 18–85
McGill University · Sites in Canada
Ages 40–80
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 40 Years to 74 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 3 started in 2021.
This study's planned enrollment of 40 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 40 across the 15 interventional studies, 12 across the 1 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
McGill University is the lead sponsor of 249 studies on the registry; 50 are open to participants now.
4 of the studies in Stroke by McGill University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07201974McGill UniversityVirtual Reality for Post-Stroke Gait Rehabilitation | 2026-11 |
| NCT06621771McGill UniversityPlaying Piano to Improve Hand Function Early After Stroke | 2027-05-01 |
| NCT04559373McGill UniversityVirtual Reality and Field Training to Enhance Community Walking After Stroke | 2027-05-31 |
| NCT07178535McGill UniversityFeasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke | 2027-07-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Stroke by McGill University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
While stroke survivors discharged from rehabilitation present with some recovery in mobility, their ability to ambulate in the community remains limited. The investigators propose to test a novel, low-cost, intensive and individually tailored intervention that combines virtual reality (VR) and field training to enhance community ambulation and participation in stroke survivors discharged from rehabilitation.
The aims are to: (1) Assess feasibility, acceptability, safety and adherence of the intervention in stroke survivors; and (2) Examine the extent to which post-intervention changes in functional walking and participation to community walking vary according to walking, cognitive and visual-perceptual abilities.
The investigators will use a virtual environment prototype simulating a shopping mall and surrounding streets, in which participants will interact using VR goggles and game controllers. Scenarios of increasing levels of complexity will be introduced. This intervention study involves a single group, multiple pre- multiple post- study design where chronic stroke participants will engage in a 4-week training program. The program will include VR training sessions performed in the clinical setting (3/week) and practice of community ambulation skills while supervised by family/caregivers (2/week). Participants will be assessed on measures of functional walking, balance \& mobility and participation to community walking. Adherence, safety and acceptability will be documented. This study will generate foundation knowledge on the response to the intervention based on individual capacities.
Ambulating in community environments requires the skills to cope with multiple, simultaneous dimensions such as walking speed and distance, etc. Such skills remain compromised in the majority of stroke survivors due to insufficient or lack of targeted practice. The investigators propose to test a new, individually-tailored intervention, developed by the research team, grounded in best evidence in community ambulation, principles of motor learning and participatory action research. This unique intervention will combine virtual reality (VR) and field training practice to optimize learning that can be generalized to daily walking activities.
Participants will engage in the 4-week, individually-tailored intervention that comprises of supervised VR training sessions (3 times/week) performed in the clinical setting. VR sessions will be completed by field training assignments. Subjects will be assessed twice prior to the intervention, immediately after the intervention and at follow up.
Generalized estimating equations will be used to compare changes in main and secondary outcomes across time points, with each personal factor of interest (e.g. walking capacity, visual-perceptual function, and cognitive function) analyzed individually while adjusting for age. Outcomes on adherence, safety and acceptability will be analyzed with descriptive statistics.
Required sample size was estimated based on Green's rule (effect size=0.5, power=80%, α=0.05) with a variance inflation factor assuming moderate within-subject correlations for 3 post-baseline measurement time points. This yields a sample size of 30. Assuming a worst-case scenario of 30% attrition rate, a total of 40 stroke subjects (20/site) will be recruited.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
People with chronic stroke and persistent deficits in walking / visual-perceptual / cognitive capacities. They can be male or female, aged from 40 to 74 years, with normal/corrected visual and auditory acuity, and present with:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will engage in a 4-week VRFT intervention that comprises of 1-hour training sessions, 3 times/week.
Other: Virtual Reality and Field Training (VRFT)
The VRFT intervention involves the intensive practice of community ambulation skills. Some of the training sessions will be performed in a virtual environment, while others will consist of field training exercises in the community. During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc.
Post-intervention change in the Six Minute Walk Test (6MWT)
The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.
Time frame: Pre-intervention (Week4) and post-intervention (Week8)
Change in the Six Minute Walk Test (6MWT) at Follow-up
The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.
Time frame: Post-intervention (Week8) and Follow-up (Week12)
Dynamic Gait Index
Developed to assess the likelihood of falling in older adults
Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
5m Walk Test
Assesses walking speed in meters per seconds over a short duration
Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
Activities-Specific Balance Confidence Scale
16-item self-reported measure of balance confidence performing various activities without losing balance or experiencing a sense of unsteadiness. Items are rated on a 0%-100% response scale, with a score of 0 representing no confidence and a score of 100 representing complete confidence.
Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
Trip Activity Log
Questionnaire to record the number of trips and walking-related activities in the community (e.g. outside home) 3 days preceding its administration
Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
Environmental Analysis of Mobility Questionnaire
Self-reported tool to assess mobility problems due to the environment
Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
Assessment of Life Habits (Life-H: mobility and community life domains)
Assesses mobility and community life habits based on the levels of accomplishment and assistance required as well as satisfaction
Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)
Adherence to intervention
Training logbook filled by researchers/clinicians (virtual reality) and subjects (field training) component)
Time frame: 3x/week over the 4-week intervention for the virtual reality component; 2x/week over the 4-week intervention for the field training component
Safety of the intervention
Assesses by systematically collecting any occurrence of adverse/unwanted events (falls, injuries, fatigue, etc).
Time frame: 3x/week over the 4-week intervention of the virtual reality component
Acceptability of the intervention
Assesses using the Technology Acceptance Model based Questionnaire (Tam-Q) based on the technology acceptance model, in which subjects will rate their perception on each dimension using a visual analog scale ranging from 0-56, with higher score representing higher acceptance to the intervention.
Time frame: Post-intervention (Week8)
Cadence
Cadence is the rate at which a person walks (steps per minute) and will be measured with the GaitRite system.
Time frame: Pre-intervention (Week4) and post-intervention (Week8)
Step length
Step length is the distance (in meters) from a point of contact with the ground of one foot to the following occurrence of the same point of contact with the other foot and will be measured with the GaitRite system.
Time frame: Pre-intervention (Week4) and post-intervention (Week8)
Step duration
Step duration is the period of time (in seconds) taken for one step is measured from an event of one foot to the following occurrence of the same event with the other foot and will be measured with the GaitRite system.
Time frame: Pre-intervention (Week4) and post-intervention (Week8)
Stance phase
Stance phase is the period of time when the foot is in contact with the ground (%) and will be measured with the GaitRite system.
Time frame: Pre-intervention (Week4) and post-intervention (Week8)
Swing phase
Swing phase is the period of time when the foot is not in contact with the ground (%) and will be measured with the GaitRite system.
Time frame: Pre-intervention (Week4) and post-intervention (Week8)
Plan to share: Yes — De-identified individual participant data for all primary and secondary outcome measure will be made available.
Time frame: Data will be available within 6 months of study completion
Access criteria: De-identified data will be deposited in a REDCap database and made available to collaborators. Data may also be made available to other researchers via an institutional data repository that will allow adhering to FAIR principles.
No publications or documents are linked to this record.
Started Apr 2021 (actual). Primary completion is estimated for May 2027, 73 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 73 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion May 2026 → May 2027 and completion Dec 2026 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.